We are 5-methoxybenzo[b]benzazepine-11-carbonyl chloride CAS:28721-08-6 manufacturer and supplier in China, Pls send inquiry of to firstname.lastname@example.org of visit www.nbinno.com our official website should you have any interests
Chemical Name: 5-methoxybenzo[b]benzazepine-11-carbonyl chloride
Oxcarbazepine impurity F [EP]
Physical and Chemical Properties:
Boiling point: 470.441ºC at 760 mmHg
Melting point: /
Flash point: 238.315ºC
Refractive index: /
Appearance: Off white to yellow powder
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Oxcarbazepine CAS:28721-07-5
Intermediates of Eslicarbazepine acetate CAS:236395-14-5
Related News: This is very visible in herbal medicines in which the API is frequently a combination of several mixtures and/or substances which when used together cause pharmacological activity on the body.Diclorhidrato de 4-piperidinilpiperidina CAS:172281-92-4 Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.rac-Des (4-ciclohexil-L-prolina) Ácido acético fosinopril CAS:123599-78-0 The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.5-Chloro-2-fluorobenzoic acid CAS:394-30-9 Pharmaceutical intermediates: chemical raw materials or chemical products used in the process of pharmaceutical synthesis, are intermediate products in the process of producing APIs, and can be further processed into APIs.The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.